Mallampati Score for Prediction and Prognosis of Postoperative Mortality and Morbidity and Safety Profiles of Patients Undergoing Laparoscopic Cholecystectomy in Qassim Region
NCT ID: NCT06005701
Last Updated: 2023-08-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
470 participants
OBSERVATIONAL
2022-01-01
2023-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation Of Preoperative Scoring Method For Peridiction Of Difficult Laparoscopic Cholecystectomy
NCT03718572
Predictors of Difficult Laparoscopic Cholecystectomy, Scoring Systems and Their Implications on the Outcomes , Sohag Experience.
NCT05859607
Subserosal Laparoscopic Cholecystectomy
NCT05770128
Intraoperative Spillage of Bile and Gallstones During Laparoscopic Cholecysetectomy
NCT04041726
Posterior Wall Sparing of Laparoscopic Cholecystectomy in Cirrhotic Patients
NCT06778928
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The Mallampati score idea is to estimate the size of the tongue related to the oral cavity and the displacement of the tongue by the laryngoscope blade was likely to be easy or difficult. It also assessed whether the mouth could be opened adequately to permit intubation
Research objectives To predict the majority of Mallampati score for the patients in Qassim region who undergoing Laparoscopic Cholecystectomy Surgery.
Method:
Observational, Multi hospital, Regional Study
Inclusion Criteria:
1. Age: 20 - 50 years
2. Laparoscopic Cholecystectomy Surgery
3. Body Mass Index (BMI): ≤ 35
Exclusion Criteria:
1. Age Less than 20 years
2. Age More than 50 years
3. Body Mass Index (BMI) \> 35
Data management and analysis plan:
All data will be entered and analyzed using SPSS V28© (IBM Corp., Armonk, NY, USA). Categorical variables will have expressed as frequencies and percentages, while continuous variables will have presented as means ± standard deviations (SDs). The chi-squared test will have used to evaluate demographic and health-related characteristics associated with name of the clinic as well as type of service provided to the patient. A p-value of less than 0.05 was considered to be statistically significant
Ethical considerations:
* All investigators completed the Bioethics certificate from The National Committee of Bioethics at King Abdulaziz City for Science and Technology.
* All investigators declare there is no conflict of interest.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Laparoscopic Cholecystectomy Surgery
3. Body Mass Index (BMI): ≤ 35
Exclusion Criteria
2. Age More than 50 years
3. Body Mass Index (BMI) \> 35
20 Years
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Qassim University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohammed Abaalkhayl
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Qassim University Medical City
Buraidah, Al-Qassim Region, Saudi Arabia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
23-33-05
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.